Decoys for docking

被引:97
作者
Graves, AP
Brenk, R
Shoichet, BK
机构
[1] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA
关键词
D O I
10.1021/jm0491187
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Molecular docking is widely used to predict novel lead compounds for drug discovery. Success depends on the quality of the docking scoring function, among other factors. An imperfect scoring function can mislead by predicting incorrect ligand geometries or by selecting nonbinding molecules over true ligands. These false-positive hits may be considered "decoys". Although these decoys are frustrating, they potentially provide important tests for a docking algorithm; the more subtle the decoy, the more rigorous the test. Indeed, decoy databases have been used to improve protein structure prediction algorithms and protein-protein docking algorithms. Here, we describe 20 geometric decoys in five enzymes and 166 "hit list" decoys-i.e., molecules predicted to bind by our docking program that were tested and found not to do so-for beta-lactamase and two cavity sites in lysozyme. Especially in the cavity sites, which are very simple, these decoys highlight particular weaknesses in our scoring function. We also consider the performance of five other widely used docking scoring functions against our geometric and hit list decoys. Intriguingly, whereas many of these other scoring functions performed better on the geometric decoys, they typically performed worse on the hit list decoys, often highly ranking molecules that seemed to poorly complement the model sites. Several of these "hits" from the other scoring functions were tested experimentally and found, in fact, to be decoys. Collectively, these decoys provide a tool for the development and improvement of molecular docking scoring functions. Such improvements may, in turn, be rapidly tested experimentally against these and related experimental systems, which are well-behaved in assays and for structure determination.
引用
收藏
页码:3714 / 3728
页数:15
相关论文
共 64 条
  • [1] High-throughput docking for lead generation
    Abagyan, R
    Totrov, M
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2001, 5 (04) : 375 - 382
  • [2] Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening
    Boehm, HJ
    Boehringer, M
    Bur, D
    Gmuender, H
    Huber, W
    Klaus, W
    Kostrewa, D
    Kuehne, H
    Luebbers, T
    Meunier-Keller, N
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (14) : 2664 - 2674
  • [3] Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
  • [4] The discovery of steroids and other novel FKBP inhibitors using a molecular docking program
    Burkhard, P
    Hommel, U
    Sanner, M
    Walkinshaw, MD
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1999, 287 (05) : 853 - 858
  • [5] Camacho CJ, 2000, PROTEINS, V40, P525, DOI 10.1002/1097-0134(20000815)40:3<525::AID-PROT190>3.0.CO
  • [6] 2-F
  • [7] Model for aqueous solvation based on class IV atomic charges and first solvation shell effects
    Chambers, CC
    Hawkins, GD
    Cramer, CJ
    Truhlar, DG
    [J]. JOURNAL OF PHYSICAL CHEMISTRY, 1996, 100 (40) : 16385 - 16398
  • [8] Chiu TL, 2000, PROTEINS, V41, P157, DOI 10.1002/1097-0134(20001101)41:2<157::AID-PROT10>3.0.CO
  • [9] 2-W
  • [10] STRUCTURE-BASED DESIGN OF NONPEPTIDE INHIBITORS SPECIFIC FOR THE HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE
    DESJARLAIS, RL
    SEIBEL, GL
    KUNTZ, ID
    FURTH, PS
    ALVAREZ, JC
    DEMONTELLANO, PRO
    DECAMP, DL
    BABE, LM
    CRAIK, CS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) : 6644 - 6648